Acadia Pharmaceuticals, Inc. (ACAD) Posts Q4 Loss of 11c/Share

March 12, 2013 4:02 PM

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) reported Q4 EPS of ($0.11) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found